Ambey Laboratories Ltd Financials
Company Logo

Ambey Laboratories Ltd Financial Statement

Ambey Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Ambey Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual120.47
Operating Expenses Annual111.40
Operating Profit Annual10.36
Interest Annual2.41
Depreciation2.52
Net Profit Annual7.72
Tax Annual-2.29

Ambey Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.40
Cash Flow from Operations-12.94
Cash Flow from Investing-5.28
Cash Flow from Financing14.48
Cash Flow at the End-3.35

Ambey Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)8.61
PBIT Margin (%)6.52
PBT Margin (%)3.83
Net PROFIT Margin (%)6.41
Return On Networth / Equity (%)38.46
Return On Networth /Employed (%)18.59
Return On Assets (%)16.28
Total Debt / Equity (X)1.48
Asset Turnover Ratio (%)2.54

Ambey Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual23.98
Total Current Assets Annual48.42
Non Current Assets Annual30.99
Total Shareholders Funds Annual31.51
Total Assets Annual79.41

Ambey Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Ambey Laboratories Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
No, Ambey Laboratories Ltd is not debt-free with a debt-to-equity ratio of 0.58.
In FY 2023 , Ambey Laboratories Ltd recorded a total revenue of approximately 104.82 Cr marking a significant milestone in the company's financial performance.
Ambey Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.1% annually, respectively..
Ambey Laboratories Ltd's current PE ratio is undefined.
Ambey Laboratories Ltd's ROCE averaged 23.5% from the FY ending March 2021 to 2023, with a median of 21.3%. It peaked at 28.1% in March 2021, reflecting strong capital efficiency over the period..
Ambey Laboratories Ltd's latest EBIT is Rs. 8.06 Cr, surpassing the average EBIT of Rs. 7.71 Cr over the 5 years..